baber/WOPTO huggingface dataset:
Patent AU-2020210168-A1 (AU)
Title: Methods and compositions for improving cognitive function
Inventor: SMITH GARDINER
IPC: A61K31/13
Filed: 2020-07-28
Abstract: The invention relates to compositions comprising a synaptic vesicle glycoprotein 2A (SV2A) 
inhibitor in an extended release and an acetylcholinesterase inhibitor (AChEI). The invention 
also relates to using such compositions in treating cognitive impairment associated with 
central nervous system disorders in a subject in need or at risk thereof, including, without 
limitation, subjects having or at risk for age-related cognitive impairment, Mild Cognitive 
Impairment (MCI), dementia, Alzheimer's Disease (AD), prodromal AD, post traumatic 
stress disorder (PTSD), schizophrenia, bipolar disorder, amyotrophic lateral sclerosis (ALS), 
cancer-therapy-related cognitive impairment, mental retardation, Parkinson's disease (PD), 
autism, compulsive behavior, and substance addiction.
Patent AU-2020216358-A1 (AU)
Title: Biometric public key system providing revocable credentials
Inventor: HERDER III CHARLES H
IPC: H04L9/08
Filed: 2020-01-29
Abstract: A device generates a biometric public key for an individual based on both the individual's biometric data and a secret S, in a manner that verifiably characterizes both while tending to prevent recovery of either. The biometric data has a Sparse Representation and is encoded in a manner to include a component of noise, such that it is challenging to identify which locations are actually encoded features. Accordingly, the biometric data are encoded as a vector by choosing marker at locations where features are present and, where features are not present, choosing noisy data. The noisy data may be chaff bit values selected collectively from a group of (a) random values and (b) independent and identically distributed values. The biometric public key may be later used to authenticate a subject purporting to be the individual, using a computing facility that need not rely on a hardware root of trust.
Patent AU-2020216988-A1 (AU)
Title: Personal support device with elongate inserts
Inventor: CHAVEZ CESAR A
IPC: B26D1/04
Filed: 2020-01-31
Abstract: A comfort device comprising a plurality of elongate inserts is disclosed herein. The comfort device can include one or more compartments configured to store the plurality of elongate inserts. The plurality of elongate inserts can have a length and a cross-section, where the cross-section has a cross-sectional area and a plurality of dimensions. The length of the inserts can be at least eight inches and at least eight times a greatest dimension of the cross-sectional area. The comfort device can include one or more openings and fastening mechanism corresponding to the one or more openings. The plurality of elongate inserts can generate tensional force in response to a force applied to the comfort device, thus providing improved elasticity for the comfort device.
Patent AU-2020222897-A1 (AU)
Title: Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
Inventor: MILLET GARY
IPC: A61K31/19
Filed: 2020-02-10
Abstract: Ketogenic compositions include a non-racemic mixture of beta-hydroxybutyrate salts and acid(s) enriched with the R-enantiomer. The compositions are enriched with the R-enantiomer to elevate ketone bodies and increase the rate at which ketosis is achieved yet contains an amount of the S-enantiomer to provide alternative benefits. Beta-hydroxybutyric acid is more rapidly absorbed and utilized by the body than salts or esters, enhances taste, and reduces the need to include citric acid or other edible acids. Beta-hydroxybutyrate salts are more slowly absorbed and utilized by the body and can provide one or more electrolytes. Compositions for increasing ketone body level in a subject may contain a dietetically or pharmaceutically acceptable carrier and a non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate, wherein the non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate contains from about 50.5% to 99.5% by enantiomeric equivalents of R-beta-hydroxybutyrate and from about 49.5% to about 0.5% by enantiomeric equivalents of S-beta-hydroxybutyrate.
Patent AU-2020239685-A1 (AU)
Title: Subsea power distribution device and system
Inventor: STROMSVIK TORBJØRN
IPC: H02J3/36
Filed: 2020-09-23
Abstract: A subsea power distribution device and system are disclosed. The subsea power distribution 
device comprises a watertight housing accommodating at least one transformer, the 
transformer having a primary winding and a plurality of secondary windings; input 
terminals, electrically connected to the primary winding and arranged to be connected to a 
remote power supply; output terminals, electrically connected to the secondary windings and 
arranged to be connected to subsea power consuming devices. The switches are arranged to 
break the connections between each secondary winding and a corresponding output terminal, 
and the switches are arranged within the watertight housing.  
Fig. 1
1/2 
100 
121 
101 
102 103 104 
FIG. 1
Patent AU-2020244461-A1 (AU)
Title: Sunscreen compositions containing a UV-absorbing polyglycerol and a non-UV-absorbing polyglycerol
Inventor: DALY SUSAN
IPC: A61K8/37
Filed: 2020-09-30
Abstract: A sunscreen composition including a polymer composition that contains a UV
absorbing polyglycerol having a UV-absorbing chromophore chemically bound thereto, and a 
cosmetically-acceptable topical carrier that contains at least one percent by weight of the 
sunscreen composition of a non-UV-absorbing polyglycerol, based on total weight of the 
sunscreen composition.
Patent AU-2020245329-A1 (AU)
Title: Genetically reprogrammed Tregs expressing CARs
Inventor: GROSS GIDEON
IPC: C07K14/54
Filed: 2020-03-26
Abstract: Nucleic acid molecules comprising a nucleotide sequence encoding an activating chimeric antigen receptor (aCARs) are provided, said aCARs comprising (i) an extracellular binding-domain specifically binding an antigen selected from an antigen of the commensal gut microflora and a self- cell surface antigen specific to the lamina propria (LP) or submucosa of the gastrointestinal tract; (ii) a transmembrane domain; (iii) an intracellular domain including at least one signal transduction element that activates and/or co- stimulates a T cell; and optionally (iv) a stalk region linking the extracellular domain and the transmembrane domain. Compositions and vectors comprising the nucleic acid molecules encoding the aCAR as well as methods for preparing regulatory T cells comprising the vectors and expressing the aCARs are further provided as are methods for treating or preventing a disease, disorder or condition manifested in excessive activity of the immune system in a subject, comprising administering to said subject the mammalian Treg expressing on its surface an aCAR. The regulatory T cells optionally express a membrane-bound homodimeric IL-10 conferring a stable Tr1 phenotype.
Patent AU-2020263709-A1 (AU)
Title: Method of treatment
Inventor: WESTON-DAVIES WYNNE H
IPC: A61P27/02
Filed: 2020-03-04
Abstract: The present invention relates to methods of treating or preventing proliferative retinal disease.
Patent AU-2020269431-A1 (AU)
Title: Adaptive deep brain stimulation of the superolateral medial forebrain bundle
Inventor: RICKERT JÖRN
IPC: A61N1/36
Filed: 2020-05-08
Abstract: System for brain stimulation of a patient, comprising: an implantable stimulator, at least one sensor component for acquiring at least one measure indicative of patient's mood, at least one implantable stimulation electrode, designed for providing electrical pulses stimulating inside the patient's brain, the at least one stimulation electrode being connectable, through an implantable connector, to the implantable stimulator, the implantable stimulator having at least one programmable channel for conducting the electrical stimulation pulses to the at least one stimulation electrode, and being adapted for receiving continuous input signals from the at the least one sensor component; a computational unit for processing the at least one measure, and a patient's body external control interface (5) for patient and/or physician interactions.
Patent AU-2020281139-A1 (AU)
Title: Prefabricated floor panel, construction and method therefor
Inventor: JONES TREVOR
IPC: E04C5/10
Filed: 2020-08-10
Abstract: PREFABRICATED FLOOR PANEL, CONSTRUCTION AND METHOD THEREFOR 
ABSTRACT 
There is provided a prefabricated floor panel (101) for use with a supporting 
structure (103) including a floor member (105) the floor member (105) defining 
a floor surface (107) and being adapted to engage with an adjacent similar 
floor panel (101) and at least one or more strengthening beams (109) 
configured to engage with the supporting structure (103) in use to support the 
prefabricated floor panel (101).
Patent AU-2020288977-A1 (AU)
Title: Methods, function manager and orchestration node of managing a port type
Inventor: MARTIN DE NICOLAS ARTURO
IPC: H04L41/00
Filed: 2020-05-29
Abstract: Embodiments relate to e.g. a method performed by an orchestration node for managing network interfaces. The orchestration node sends to a function manager, trunk-port specific information of a trunk port to enable the function manager to unambiguously orchestrate trunk ports.
Patent AU-2020296473-A1 (AU)
Title: Method of injecting ammonia fuel into a reciprocating engine
Inventor: WIBBERLEY LOUIS JAMES
IPC: F02M21/02
Filed: 2020-06-15
Abstract: A method of injection of liquid or gaseous ammonia fuel into a reciprocating engine that includes at least two cylinders, each cylinder including a piston that moves reciprocally within that cylinder, each cylinder having a head location at one end located opposite to a compression end of the piston and defining a combustion chamber therebetween, the cylinder including at least one inlet valve through which combustion gases are fed into the combustion chamber and at least one exhaust valve through which spent combustion gases egress the combustion chamber, the piston moving the cylinder in a cycle between top dead center where the piston is located closest to the head location and bottom dead center where the piston is located furthest from the head location, and including at least one fuel injector located at or in the head location, and wherein the method comprises: injecting the ammonia fuel into the combustion chamber of each cylinder as at least one fuel jet with a timing of: after the at least one exhaust valve of the respective cylinder is substantially closed; and before the respective piston moves to at most 35 degrees, preferably at most 45 degrees, prior to top dead centre.
Patent AU-2020301813-A1 (AU)
Title: Method of inhibiting or activating gamma delta T cells
Inventor: BEHREN ANDREAS
IPC: A61P37/02
Filed: 2020-06-26
Abstract: The present disclosure relates to methods for inhibiting activation of γδ T cells that express a Vγ9+ TCR in a subject by administering a BTN2A1 antagonist to a subject as well as methods for inducing or enhancing γδ T cells that express a Vγ9+ TCR in a subject by administering a BTN2A1 antagonist to a subject. The disclosure additionally relates to BTN2A1 antagonists and BTN2A1 agonists.
Patent AU-2020313198-A1 (AU)
Title: Dismantlable dispenser for a coffee machine
Inventor: QUARATESI GUIDO
IPC: A47J31/44
Filed: 2020-06-17
Abstract: The coffee machine comprises an infused coffee dispenser (1) comprising a hollow body (1a, 1b) delimiting at least one dispensing chamber (31) for dispensing infused coffee and having at least one inlet hole (32) for the infused coffee and at least one dispensing hole (33) for dispensing the infused coffee, the hollow body (1a, 1b) of the infused coffee dispenser (1) being formed into several pieces comprising at least one dismantlable first piece (1a) adapted for opening a direct access to the inside of the dispensing chamber (31).
Patent AU-2020323624-A1 (AU)
Title: Avoidance of redundant signaling in multi-layer video bitstreams
Inventor: WANG YE-KUI
IPC: H04N7/12
Filed: 2020-10-06
Abstract: A method of decoding is provided. The method includes receiving a sub-bitstream having a sequence parameter set (SPS) with a profile tier level (PTL) syntax structure for an output layer set (OLS) with only one layer; setting a number of layers in the OLS equal to one based on the OLS having the only one layer; obtaining the PTL syntax structure for the OLS with the one layer from the SPS when the number of layers in the OLS has been set equal to one; and decoding a picture from the only one layer using the PTL syntax structure to obtain a decoded picture. A corresponding method of encoding is also provided.
Patent AU-2020324183-A1 (AU)
Title: Anti-TNFR2 antibody and use thereof
Inventor: ZHAO XINYAN
IPC: A61K39/395
Filed: 2020-07-31
Abstract: An antibody or an antigen-binding fragment thereof capable of specifically binding to TNFR2, the antibody or the antigen-binding fragment thereof is capable of regulating the function of immune cells and may be used as a medicament to treat diseases related to immune abnormalities, such as tumors.
Patent AU-2020342592-A1 (AU)
Title: Method of separating different constituents of a concrete for deconstruction
Inventor: CORDONNIER ALAIN
IPC: B02C17/18
Filed: 2020-09-01
Abstract: The invention relates to a method of separating different constituents of a fine fraction that is produced in a prior method for separating a concrete for deconstruction.
Patent AU-2020357714-A1 (AU)
Title: Selective chemical fining of small bubbles in glass
Inventor: WEIL SCOTT
IPC: C03B5/235
Filed: 2020-09-29
Abstract: A method of fining glass is disclosed that includes flowing a molten glass bath (22) through a fining chamber (20, 420). The molten glass bath (22) has an undercurrent (62) that flows beneath a skimmer (50, 250, 350, 481, 589) that is partially submerged in the moken glass bath (22). One or more fining agents are introduced into the undercurrent (62) of the molten glass bath (22) directly beneath the skimmer (50, 250, 350, 481, 589).from a dissolvable fining material component (68, 268, 368, 468). In this way, the fining agent(s) may selectively target the gas bubbles (88) drawn under the skimmer (50, 250, 350, 481, 589) within the undercurrent (62) of the molten glass (22) for removal. The method may be employed to fine molten glass produced in a submerged combustion melter (14). A fining vessel (10) for fining molten glass is also disclosed.
Patent AU-2020363865-A1 (AU)
Title: Androstane derivatives with activity as pure or predominantly pure stimulators of SERCA2a for the treatment of heart failure
Inventor: CERRI ALBERTO
IPC: C07J43/00
Filed: 2020-10-08
Abstract: Compounds and compositions for the activation of SERCA2a are disclosed. In particular, provided are compounds that act as predominantly pure or pure SERCA2a activators while only moderately inhibiting the Na
Patent AU-2020378420-A1 (AU)
Title: Identifying and quantifying components in a high-melting-point liquid
Inventor: PAMPLIN KIM
IPC: B05B17/06
Filed: 2020-11-06
Abstract: Apparatus, systems, and methods for identifying and quantifying chemical components in a high-melting-point liquid. One such method includes: receiving, into a nebulizer assembly, a high-melting-point liquid from a molten liquid conduit; aerosolizing, using the nebulizer assembly, at least a portion of the received high-melting-point liquid; delivering, into one or more instruments, the aerosolized high-melting-point liquid from the nebulizer; and chemically analyzing, using the one or more instruments, the aerosolized high-melting-point liquid.
Patent AU-2020386643-A1 (AU)
Title: Process for the synthesis of (3-chloro-2-pyridyl)hydrazine
Inventor: CHOCKALINGAM DEVARAJAN
IPC: C07D213/77
Filed: 2020-11-22
Abstract: Described herein are novel methods of synthesizing (3-chloro-2-pyridyl)hydrazine. Compounds prepared by the methods disclosed herein are useful for preparation of certain anthranilamide compounds that are of interest as insecticides, such as, for example, the insecticides chlorantraniliprole and cyantraniliprole.
Patent AU-2020398854-A1 (AU)
Title: Systems and methods for persistence across applications using a content switching server
Inventor: MUTHIAH MANIKAM
IPC: H04L65/40
Filed: 2020-11-23
Abstract: Disclosed herein includes a system, a method, and a device for providing persistence across applications using a content switching server. A device can receive a first request from a client for a version of an application having different versions provided by one or more servers. The device can provide access to each version of the application via different load balancing virtual servers. A content switching virtual server of the device can select a load balancing virtual server to handle the first request for the version of the application. The content switching virtual server can generate a session identifier for a session between the client and the version of the application to persist the session with the selected load balancing virtual server for subsequent requests from the client for the version of the application.
Patent AU-2020408331-A1 (AU)
Title: Anionic surfactant impact on virucidal efficacy
Inventor: HANSON CATHERINE
IPC: A01P1/00
Filed: 2020-12-16
Abstract: Virucidal compositions including at least one acid and an alpha olefin sulfonate anionic surfactant are provided. In particular, virucidal efficacy against Murine Norovirus is provided at improved efficacy rates beyond comparative anionic surfactants. Methods of using a virucidal composition are also provided.
Patent AU-2020429371-A1 (AU)
Title: Medium supplement for high-yield industrial culture of fastidious anaerobes and medium composition containing the same
Inventor: SEO JAE-GU
IPC: C12N1/20
Filed: 2020-12-28
Abstract: The present invention relates to a medium supplement for high-yield culture of anaerobes 
including N-acetylhexosamine, L-aspartic acid, L-cysteine and cobalamin, a medium com
position medium supplement for high-yield culture of anaerobes including the medium 
supplement, and a culture method using the same. According to the present invention, it is 
possible to provide an innovative method which is capable of achieving high-concentration 
culture of anaerobes, which are extremely difficult to culture in high yield, and is cost-effective, 
and in particular, is capable of culturing large amounts of fastidious aerobes suitable for use in 
food and pharmaceutical applications.
Patent AU-2020451849-A1 (AU)
Title: An outlet piece assembly for a horizontal plate and frame-type filter, such as a tower press
Inventor: MUSTAKANGAS MIRVA
IPC: B01D25/12
Filed: 2020-06-03
Abstract: The present disclosure relates to an outlet piece assembly (1) for a horizontal plate and frame-type filter, such as tower press. The disclosure is based on the idea of providing the outlet piece assembly (1) as having a base (3) removably attachable to a filter press (e.g., to the filter plate (8) or plate frame (9) thereof), and a lid (4) removably fixed to the 5 base (3), such that an internal conduit (2) of the outlet piece assembly running between a vat end and a discharge end is formed between the base (3) and the lid (4). This enables a part of an associated filtrate vat component, such as the vat liner (5), to be received between the base (3) and the lid (4), thereby ensuring secure sealing between these components.
Patent AU-2021221739-A1 (AU)
Title: Learning aid
Inventor: LAWTON JOHN
IPC: B43L13/20
Filed: 2021-08-25
Abstract: P1797AU00 
ABSTRACT 
A drawing template comprising 
one or more arc-defining portions for a pencil to bear against to mark out an arc of 
at least 1800; 
5 a origin feature for identifying an origin of the arc; and 
one or more radial-line-defining portions for a pencil to bear against to mark out a 
radial line.
112 1 
L 
00 pp 
ep6 
Figure 1 
PRIOR ART 
Figure 2 
69 Circles 
00 90o 0 770 
13 
3 
-F-ue 
37 Rhombus 45° -" ,r 
39o 9 Oso%5 
4 Kt 
9 
0- ; 5 
Figure 3
Patent AU-2021229480-A1 (AU)
Title: Surgical tissue retractor holding frame
Inventor: HARPER KEITH
IPC: A61B17/02
Filed: 2021-03-02
Abstract: Retractor holding frames and related methods are provided. The frame includes a support body including a first bore extending transversely from a first side of the support body to a second side of the support body opposite the first side, and a second bore extending transversely from the second side to the first side. The frame includes a left support frame arm including a first annular hub configured to be disposed within the first bore and a first plurality of posts disposed along an outer edge of the left support frame arm configured to retain a first retractor in a first orientation. The frame includes a right support frame arm including a second annular hub configured to be disposed within the second bore and a second plurality of posts disposed along an outer edge of the right support frame arm configured to retain a second retractor in a second orientation.
Patent AU-2021239811-A1 (AU)
Title: Elastomer with tunable properties and method of rapidly forming the elastomer
Inventor: SOTTOS NANCY R
IPC: A61L27/22
Filed: 2021-03-10
Abstract: A method of rapidly forming an elastomer with tunable properties is described herein. The method includes preparing a monomer solution comprising a catalyst and one or more monomers including 1,5- cyclooctadiene (COD). The one or more monomers may further include dicyclopentadiene (DCPD), and each of the COD and the DCPD may be present in the monomer solution at a predetermined volume percentage. A region of the monomer solution is activated to initiate an exothermic polymerization reaction and generate a self-propagating polymerization front, which moves through the monomer solution and polymerizes the one or more monomers. Thus, an elastomer having predetermined properties is rapidly formed.
Patent AU-2021250849-A1 (AU)
Title: Method and system for forming a support structure such as a bed or chair for a user according to the user’s requirements
Inventor: PIRAINO MARIO
IPC: A47C27/14
Filed: 2021-10-12
Abstract: According to the present invention, there is provided a method of forming a bed to match a user 
including the steps of: 
a) Determining a plurality of essential positions along the profile of the user; 
b) Determining required support needs at the essential positions of the profile of the user; and 
c) Forming a bed with differing support characteristics along the length of the bed wherein the 
matching of the bed to the user matches the required support needs of the user at the essential 
positions of the profile of the user.  
Preferably the differing support characteristics matching required support needs includes one or 
more of: 
a) Depression, being positive or negative depression, to allow varying width of a portion of user body 
at essential positions along the profile of the user; 
b) Support to support the portion of user body at essential positions along the profile of the user; 
and 
c) Pressure attenuation to vary the pressure on the width of portion of user body at essential 
positions along the profile of the user to match: 
i) The weight at the width of portion of user body at essential positions along the profile of the user; 
or 
ii) The cushioning contact need at the width of portion of user body at essential positions along the 
profile of the user.  
The essential positions of the profile of the user can include at least one or more of Shoulder area, 
Lumbar area and Hip area.
eplacement Sheet 
LO 
00 
CO
1/16